Covered recipient · General Payments record
AMANDA K BROWN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,436.43
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $291.35 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $102.06 | 6 |
| ABBVIE INC. | $58.09 | 4 |
| Amgen Inc. | $36.03 | 2 |
| Corcept Therapeutics | $33.30 | 2 |
| Astellas Pharma US Inc | $30.27 | 2 |
| PFIZER INC. | $16.51 | 1 |
| Janssen Biotech, Inc. | $15.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.43 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106831362 | CMS |
| ABBVIE INC. | $13.57 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106831364 | CMS |
| ABBVIE INC. | $13.74 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106831366 | CMS |
| ABBVIE INC. | $16.35 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106831368 | CMS |
| Amgen Inc. | $18.07 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115464627 | CMS |
| Amgen Inc. | $17.96 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115464632 | CMS |
| Astellas Pharma US Inc | $15.20 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139500728 | CMS |
| Astellas Pharma US Inc | $15.07 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139531684 | CMS |
| Corcept Therapeutics | $17.35 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117746523 | CMS |
| Corcept Therapeutics | $15.95 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117746579 | CMS |
| Janssen Biotech, Inc. | $15.09 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078678355 | CMS |
| Novo Nordisk Inc | $16.60 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100558895 | CMS |
| Novo Nordisk Inc | $17.38 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100389475 | CMS |
| Novo Nordisk Inc | $14.66 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100438827 | CMS |
| Novo Nordisk Inc | $19.30 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100257794 | CMS |
| Novo Nordisk Inc | $18.23 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100267544 | CMS |
| Novo Nordisk Inc | $15.89 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100290708 | CMS |
| PFIZER INC. | $16.51 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131276150 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.